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Abstract
Background: Hemorrhagic shock followed by resuscitation is conceived as an insult frequently induces a systemic
inflammatory response syndrome and oxidative stress that results in multiple-organ dysfunction syndrome
including acute lung injury. MK-886 is a leukotriene biosynthesis inhibitor exerts an anti inflammatory and
antioxidant activity.
Objectives: The objective of present study was to assess the possible protective effect of MK-886 against
hemorrhagic shock-induced acute lung injury via interfering with inflammatory and oxidative pathways.
Materials and methods: Eighteen adult Albino rats were assigned to three groups each containing six rats:
group I, sham group, rats underwent all surgical instrumentation but neither hemorrhagic shock nor
resuscitation was done; group II, Rats underwent hemorrhagic shock (HS) for 1 hr then resuscitated with
Ringer’s lactate (1 hr) (induced untreated group, HS); group III, HS + MK-886 (0.6 mg/kg i.p. injection 30 min
before the induction of HS, and the same dose was repeated just before reperfusion period). At the end of
experiment (2 hr after completion of resuscitation), blood samples were collected for measurement of serum
tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6). The trachea was then isolated and bronchoalveolar
lavage fluid (BALF) was carried out for measurement of leukotriene B4 (LTB4), leukotriene C4 (LTC4)a n dt o t a l
protein. The lungs were harvested, excised and the left lung was homogenized for measurement of
malondialdehyde (MDA) and reduced glutathione (GSH) and the right lung was fixed in 10% formalin for
histological examination.
Results: MK-886 treatment significantly reduced the total lung injury score compared with the HS group (P < 0.05).
MK-886 also significantly decreased serum TNF-a & IL-6; lung MDA; BALF LTB4, LTC4 & total protein compared with
the HS group (P < 0.05). MK-886 treatment significantly prevented the decrease in the lung GSH levels compared
with the HS group (P < 0.05).
Conclusions: The results of the present study reveal that MK-886 may ameliorate lung injury in shocked rats via
interfering with inflammatory and oxidative pathways implicating the role of leukotrienes in the pathogenesis of
hemorrhagic shock-induced lung inflammation.
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Hemorrhagic shock (HS) is a commonly encountered
complication within a blunt traumatic or surgical injury.
Hemorrhagic shock followed by resuscitation (HSR) is
conceived as an insult frequently induces a systemic
inflammatory response syndrome (SIRS) that results in
multiple-organ dysfunction syndrome (MODS) [1,2]
including acute lung injury (ALI), which is a major clin-
ical problem, leading to significant mortality and mor-
bidity [1,3]. The mechanism of pathogenesis of SIRS in
the field of HS is complex and a variety of mechanisms
are implicated. The most widely recognized mechanisms
are ischemia and reperfusion (I/R) and stimulation of
cells of the innate immune system [4]. Ischemia and
reperfusion is mainly participating in oxidative stress
and SIRS arising during post-ischemic resuscitation. I/R
injury is, by itself, a potent inflammatory trigger,
increasing cytokine release, reactive oxygen species gen-
eration, and endothelial activation, with consequent
nitric oxide production and expression of adhesion
molecules [5]. Neutrophils are the major cellular ele-
ments involved in acute lung inflammation after resusci-
tated hemorrhagic shock [6]. Studies have shown that
neutrophils are activated following HS [7] and that lung
injury is associated with an increased neutrophils accu-
mulation in the lungs after HS [8]. The activated neu-
trophils appear to infiltrate the injured lung in parallel
with increased expression of adhesion molecules on
endothelial cells and elevated local chemokines/cyto-
kines levels following HS [7].
MK-886 (investigational compound) is a highly potent
inhibitor of leukotriene for m a t i o ni nv i v oa n di nv i t r o
[9]. This compound inhibits leukotriene biosynthesis
indirectly by a mechanism through the binding of a
membrane bound 5-lipoxygenase-activating protein
(FLAP), thereby inhibiting the translocation and activa-
tion of 5-lipoxygenase [10,11]. The 5-lipoxygenase inhi-
bition by MK-886 prevents stimulated neutrophil
adherence and chemotaxis and neutrophil mediated
lung injury in vitro [12]. MK-886 has been shown to
reduce the extravasation of plasma [13] and prevent the
leukocyte adhesion to the endothelium [14] in experi-
mental animals. MK-886 was found to be effective in
prevention of liver and intestine injury by reducing
apoptosis and oxidative stress in a hepatic I/R model.
Anti-inflammatory properties and inhibition of lipid per-
oxidation by MK-886 could be protective for these
organs in I/R injury [15]. MK-886 significantly reduces
acute colonic mucosal inflammation in animals with
colitis when the treatment is performed during the early
phase of the inflammatory response [16]. Recently, treat-
ment of mice with MK-886 significantly abolished the
increase in the BALF total protein level in a model of
acute lung injury following hemorrhagic shock [17].
2. Materials and methods
2.1. Animals and Study Design
A total of eighteen adult male Albino rats weighing 150-
220 g were purchased from Animal Resource Center,
the Institute of embryo research and treatment of infer-
tility, Al-Nahrain University. They were housed in the
animal house of Kufa College of Medicine in a tempera-
ture-controlled (25°C) room with alternating 12-h light/
12-h dark cycles and were allowed free access to water
and chow diet until the start of experiments. All experi-
ments were approved by the Animal Care and Research
Committee of the University of Colorado Denver, and
this investigation conforms with the Guide for the Care
and Use of Laboratory Animals (National Research
Council, revised 1996).
After the 1
st week of acclimatization the rats were ran-
domized into three groups as follow:
I. Sham group: this group consisted of 6 rats; rats
underwent the same anesthetic and surgical procedures
for an identical period of time as shock animals, but
neither hemorrhage nor fluid resuscitation was
performed.
II. Control group: (induced untreated group): this
group consisted of six rats; rats underwent hemorrhagic
shock (for 1 hr) then resuscitated with Ringer’s lactate
(RL) (for 1 hr), and left until the end of the experiment.
III. MK-886 treated group: this group consisted of 6
rats; Rats received MK-886 0.6 mg/kg i.p. injection 30
min before the induction of HS, and the same dose was
repeated just before reperfusion period.
❖Both sham and induced untreated rats received the
same volume of the vehicle.
The drug was purchased from (Cayman chemical,
USA) and prepared immediately before use as a homo-
g e n i z e ds o l u t i o ni n2 %e t h a n o l[ 1 5 ] .E t h a n o lw a su s e d
to form a homogenized drug. Each dose was homoge-
nized in 1ml ethanol and injected via i.p [15].
2.2. Hemorrhagic Shock Protocol
Animals were intraperitoneally anesthetized with 80 mg/
kg ketamine and 8 mg/kg xylazine [18] and subjected to a
50% blood loss (30 ml/kg) via intracardiac puncture from
the left side of the chest over 2 min and left in shock state
for 1 hr. The animals were then resuscitated with two
times blood loss (60 ml/kg) using i.v lactated Ringers via
tail over 1 hr [19]
.The sham group underwent all instru-
mentation procedures, but neither hemorrhage nor resus-
citation was carried out. Animals were allowed to breathe
spontaneously throughout the experiment. Two hour after
the completion of resuscitation, rats were again anesthe-
tized and sacrificed by exsanguinations, where the chest
cavity was opened and blood samples were taken directly
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oalveolar lavage fluid (BALF) was carried out. The lungs
were harvested, excised and the left lung was homogenized
and stored until use for the study and the right lung was
fixed in 10% formalin for histological examination.
2.3. Preparation of Blood Samples and Cytokine Assays
About 3 ml of blood was collected from the heart of
each rat. The blood sampling was done at the end of
the experiment (2hr after the completion of resuscita-
tion). The blood samples were allowed to clot at 37°C
and then centrifuged at 3000 rpm for 15 min; Sera were
removed, and analyzed for determination of serum
TNF-a and IL-6. Serum TNF-a and IL-6 were quantified
according to the manufacturer’si n s t r u c t i o n sa n dg u i d e -
lines using enzyme-linked immunosorbent assay
(ELISA) kits (IMMUNOTECH. France).
2.4. Preparation of Bronchoalveolar Lavage Fluid and
determination of leukotrienes and total protein
The trachea was then isolated, and bronchoalveolar lavage
fluid was obtained by washing the airways four times with
5 ml of phosphate buffered saline. The bronchoalveolar
lavage fluid was centrifuged at 1200 × g for 10 min at 4°C.
The supernatant was collected and stored at -70°C until
analyzed for LTB4,L T C 4 and total protein [20]. The BALF
levels of LTB4 and LTC4 were quantified according to the
manufacturer’s instructions and guidelines using ELISA
kits (USBiological. USA). Cell free BALF was evaluated for
total protein content using Biuret method (photometric
colorimetric test total proteins) [21].
2.5. Tissue Preparation for Oxidative Stress Measurement
The lung specimens were homogenized with a high
intensity ultrasonic liquid processor and sonicated in
phosphate buffered saline containing 0.1mmol/L EDTA
(pH7.4) (10%). The homogenate was centrifuged at 10
000 rpm for 15 min at 4°C and supernatant was used
for determination of GSH and MDA [18]. The MDA
levels were assayed for products of lipid peroxidation by
monitoring thiobarbituric acid reactive substance forma-
tion according to the method of Buege and Aust in
1978 [22]. Lipid peroxidation was expressed in terms of
MDA equivalents using an extinction coefficient of 1.56
×1 0
5 M
−1 cm
−1 and results were expressed as nmol
MDA/g tissue. GSH measurements were performed
using a colorimetric method at 412nm (BioAssay Sys-
tems’ QuantiChrom™ Glutathione Assay Kit).
2.6. Tissue Sampling for Histopathology
At the end of the experiment, rats were sacrificed and
the lung was harvested. All specimens were immediately
fixed in 10% buffered formalin. After fixation they were
processed in usual manner. The sections were examined
by microscope then the histological changes were
determined.
The degree of lung injury was assessed using the scor-
ing system described by Matute-Bello et al. that graded
congestion of alveolar septae, intra-alveolar cell infil-
trates, and alveolar hemorrhage [23]. Each parameter
was graded on a scale of 0-3, as follows: alveolar septae,
0: septae thin and delicate, 1: congested alveolar septae
in < 1/3 of the field, 2: congested alveolar septae in 1/3-
2/3 of the field, 3: congested alveolar septae in > 2/3 of
the field; intra-alveolar cell infiltrates, 0: < 5 intra-alveo-
lar cells per field, 1: 5 to 10 intra-alveolar cells per field,
2: 10 to 20 intra-alveolar cells per field, 3: > 20 intra-
alveolar cells per field; Alveolar hemorrhage, 0: no
hemorrhage, 1: at least 5 erythrocytes per alveolus in 1
to 5 alveoli, 2: at least 5 erythrocytes in 5 to 10 alveoli,
3: at least 5 erythrocytes in > 10 alveoli. The total lung
injury score was calculated be adding the individual
scores for each category and lung injury was categorized
according to the sum of the score to normal (0), mild
(1-3), moderate (4-6) and severe injury (7-9). The histo-
logical sections were evaluated by a pathologist without
prior knowledge of the treatment given to the animals.
2.7. Statistical Analysis
Statistical analyses were performed using SPSS 12.0 for
windows.lnc. Data were expressed as mean ± SEM. Ana-
lysis of Variance (ANOVA) was used for the multiple
comparisons among all groups followed by post-hoc
tests using LSD method. The histopathological grading
of lung changes is a non-normally distributed variable
measured on an ordinal level of measurement; therefore
non-parametric tests were used to assess the statistical
significance involving this variable. The statistical signifi-
cance of difference in total score between more than 2
groups was assessed by Kruskal-Wallis test, while
Mann-Whitney U test was used for the difference
between 2 groups. In all tests, P < 0.05 was considered
to be statistically significant.
3. Results
3.1. Effect on Proinflammatory Cytokines (TNF-a and IL-6)
At the end of the experiment, the serum TNF-a and IL-
6 levels were significantly higher in the HS group when
compared with the sham group (P < 0.05). Treatment
with MK-886 significantly decreased the serum TNF-a
and IL-6 levels when compared with the HS group (P <
0.05). The TNF-a and IL-6 values for the different
groups are shown in table 1 and Figures 1&2.
3.2. Effect on Lung MDA and GSH Levels
The MDA levels, measured as a major degradation pro-
duct of lipid peroxidation in the pulmonary tissue, were
found to be significantly higher in HS group as
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treatment with MK-886 abolished these elevations (P <
0.05). The HS caused a significant decrease in lung GSH
level (P < 0.05) when compared with the sham group,
while in the MK-886 treated group, the lung GSH level
was found to be preserved (P < 0.05) and not signifi-
cantly different from that of the sham group. The MDA
and GSH values for the different groups are shown in
table 2 and Figure 3, 4.
3.3. Effect on Leukotrienes (LTB4 & LTC4)
At the end of the experiment; the LTB4 and LTC4 levels
in the BALF were significantly increased in the HS
g r o u pa sc o m p a r e dw i t ht h es h a mg r o u p( P <0 . 0 5 ) .
Treatment with MK-886 significantly decreased the
BALF LTB4 and LTC4 levels when compared with the
HS group (P < 0.05). The LTB4 and LTC4 values for the
different groups are shown in table 3 and Figure 5, 6.
3.4. Effect on BALF Total Protein
At the end of the experiment; the total protein level of
the BALF was significantly increased in HS group as
c o m p a r e dw i t hs h a mg r o u p( P < 0.05). Treatment with
MK-886 significantly decreased the BALF total protein
levels when compared with the HS group (P <0 . 0 5 ) .
The total protein values for the different groups are
shown in table 4 and Figure 7.
3.5. Histological finding
A cross section of sham rat’s lung showed the normal
appearance of all three parameters (thin and delicate
alveolar septae, no intra-alveolar cell infiltrates and no
alveolar hemorrhage) Figure 8. All rats in this group
showed normal lung appearance (100%) as shown in
table 5.
There was statistically significant difference between
induced untreated (HS) group and sham group (P <
0.05) and the total score mean of the HS group showed
moderate lung injury. 66.7% of the group had moderate
lung injury and 33.3% had severe lung injury as shown
in table 5, 6 and Figures 9, 10.
Treatment of rats with MK-886 ameliorated the lung
injury significantly (P < 0.05) as compared with induced
untreated group and the total score mean of this group
showed mild lung injury (Figure 11). 16.7% of the group
had normal histopathological appearance and 83.3% of
the group had mild lung injury as shown in table 5.
Discussion
The present study demonstrates that HS causes ALI, as
evidenced by biochemical and histologic changes. MK-
886 prevented the biochemical changes and protected
the lung morphology after HS. Although leukotriene-
shave been known to be associated with the I/R injury
in other tissues, including intestine [24]kidney [25],
myocardium [26] and liver [27], there are only a few
Table 1 Serum TNF-a and IL-6 levels (pg/ml) of the three
experimental groups at the end of the experiment
Group TNF-a (pg/ml) IL-6 (pg/ml)
1. Sham 19.4 ± 2.12 21.16 ± 2.61
2. Control (HS) 93.3 ± 6.48* 44.84 ± 2.33*
3. MK-886 treated group 49.4 ± 3.81
† 29.78 ± 1.27
†
The data expressed as mean ± SEM (N = 6 in each group).
￿ P < 0.05 vs. sham group,
† P < 0.05 vs. HS (induced untreated) group
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Figure 1 The mean of serum TNF-a level (pg/ml) in the three
experimental groups at the end of the experiment.
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Figure 2 The mean of serum IL-6 level (pg/ml) in the three
experimental groups at the end of the experiment.
Table 2 Lung MDA and GSH levels of the three
experimental groups at the end of the experiment
Group Lung MDA (nmol/g) Lung GSH (μmol/g)
1. Sham 95 ± 2.78 4.36 ± 0.27
2. Control (HS) 157 ± 6.15* 2.12 ± 0.25*
3. MK-886 treated group 107.2 ± 3.76
† 3.7 ± 0.35
†
The data expressed as mean ± SEM (N = 6 in each group).
￿ P < 0.05 vs. sham group,
† P < 0.05 vs. HS (induced untreated) group
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shock-induced lung injury and 5-lipoxygenase pathway
products, where two studies demonstrated that the 5-
lipoxygenase pathway products meditate acute lung
injury following hemorrhagic shock [28,29]. And it has
been demonstrated that LTB4 levels were significantly
increased in the rat lungs following T/HS [30]. Studies
in humans confirm elevated levels of LTB4,L T C 4,L T D 4
in BAL, pulmonary edema fluid, and plasma in patients
with ALI compared with “at-risk” group or those with
hydrostatic edema [31,32]. In the present study a signifi-
cant increase in BALF leukotriene (LTB4 &L T C 4) levels
were found in the shocked rats as compared with sham
group. The increased leukotriene level in shocked rats
might be due to the associated splanchnic I/R, which
activates gut PLA2-mediated release of AA into the
lymph where it is delivered to the lungs [33]. Arachido-
nic acid is a biologically active lipid released from the
cellular membrane by PLA2 that can engage the LTB4
receptor and initiate LTB4 production with autocrine
effects [34]. Arachidonic acid also promotes 5-lipoxy-
genase translocation to the nucleus, a key step in leuko-
trienes production [35]. Additionally, it is known that
ischemia elevates cytosolic calcium concentration, which
in turn elevates PLA2 and lipoxygenase activity, generat-
ing leukotrienes. Furthermore, increased leukotriene
level might be due to the leukocytes accumulated in the
lungs as observed in the histological section of the
shocked rat lung where activated neutrophils following
hemorrhagic shock are capable of releasing cytotoxic
products including leukotrienes, and the intrinsic 5-
lipoxygenase activity is required for neutrophil adher-
ence and chemotaxis and neutrophil-mediated lung
injury [36]. In addition to neutrophils, alveolar macro-
phages and circulating macrophages aggravate lung
injury and alveolar neutrophil sequestration in hemor-
rhagic shock [37] and might contribute to further
release of leukotrienes. In this study we have demon-
strated that treatment with MK-886 appeared to have a
significant decrease in BALF leukotrienes (LTB4 &
LTC4) level in the shocked rats in comparison with the
induced untreated group. It is reported that selective
inhibition of leukotriene biosynthesis by MK-886 pre-
vents postischemic leukotrienes accumulation and the
microcirculatory changes after I/R in the striated muscle
in vivo [14]. Furthermore, MK-886 was found to be a
potent and specific inhibitor of both LTB4 and LTC4
synthesis in human phagocytes [9,38].
Hemorrhagic shock is considered as an insult fre-
quently leading to systemic inflammatory response syn-
drome including the systemic release of proinflammatory
cytokines which is central in the inflammatory response.
Previous studies have shown that levels of IL-6 and TNF-
a significantly increased following trauma-hemorrhage
and remain elevated for several hours [39]. The results in
present study are consistent with that reported by Vin-
cenzi et al. [40] Who found that a significant increase in
the TNF-a and IL-6 levels in shocked rats in comparison
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Figure 3 The mean of lung MDA level (nmol/g) in the three
experimental groups at the end of the experiment.
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Figure 4 The mean of lung GSH level (μmol/g) in the three
experimental groups at the end of the experiment.
Table 3 BALF LTB4 and LTC4 level (pg/ml) of the three
experimental groups at the end of the experiment
Group BALF LTB4 (pg/ml) BALF LTC4 (pg/ml)
1. Sham 0.42 ± 0.02 0.33 ± 0.05
2. Control (HS) 1.84 ± 0.03* 8.64 ± 0.31*
3. MK-886 treated group 0.37 ± 0.04
† 0.28 ± 0.05
†
The data expressed as mean ± SEM (N = 6 in each group).
￿ P < 0.05 vs. sham group,
† P < 0.05 vs. HS (induced untreated) group
Table 4 BALF total protein level (g/l) of the three
experimental groups, at the end of the experiment
Group BALF total protein (g/l)
1. Sham 7.2 ± 0.5
2. Control (HS) 14.7 ± 0.57*
3. MK-886 treated group 8 ± 0.3
†
The data expressed as mean ± SEM (N = 6 in each group).
￿ P < 0.05 vs. sham group,
† P < 0.05 vs. HS (induced untreated) group
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macrophages and neutrophils have been shown to play a
pivotal role in the propagation of SIRS following resusci-
tated shock and could be considered the main source of
inflammatory cytokines including TNF-a and IL-6. In
this study MK-886 significantly reduced the elevation of
IL-6 and TNF-a l e v e li nt h es h o c k e dr a t sa sc o m p a r e d
w i t hi n d u c e du n t r e a t e dg r o u ps u g g e s t i n gt h a tM K - 8 8 6
has protective effect in hemorrhagic shock-induced acute
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Figure 5 The mean of BALF LTB4 level (pg/ml) in the three
experimental groups at the end of the experiment.
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Figure 6 The mean of BALF LTC4 level (pg/ml) in the three
experimental groups at the end of the experiment.
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Figure 7 The mean of BALF total protein level (g/l) in the three
experimental groups at the end of the experiment.
Figure 8 Photomicrograph of lung section of normal rats
shows the normal architecture. The section stained with
Haematoxylin and Eosin (X 10).
Table 5 The differences in histopathological grading of
abnormal lung changes among the three experimental
groups
Histopathological grading Study group
Sham Control (HS) MK-886
N% N % N %
Normal 6 100 0 0 1 16.7
Mild 0 0 0 0 5 83.3
Moderate 0 0 4 66.7 0 0
Severe 0 0 2 33.3 0 0
Total 6 100 6 100 6 100
Figure 9 Photomicrograph of lung section with moderate
injury. The section stained with Haematoxylin and Eosin (X 10).
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by MK-886 significantly attenuated the generation of
TNF-a by mast cells activated by FcεRI cross-linkage
[41]. MK-886 pretreatment attenuated subsequent pul-
monary expression of TNF- a in a mouse model of bron-
chial inflammation and hyperreactivity [42]. LTB4
augments IL-6 production in human monocytes by
increasing both IL-6 gene transcription and mRNA stabi-
lization [43,44]. activation of NF-Ba n dN F - I L - 6t r a n -
scriptional factors may be important in this enhancement
of IL-6 release [44]. Furthermore, TNF-a production is
enhanced by LTC4 and LTD4 [45]. So that, inhibition of
LTB4 and CysLTs synthesis by MK-886 might result in
lowering TNF-a and IL-6 levels.
Through examination of metabolic processes, GSH has
been shown to be important in host defenses against oxi-
dative stress [46]. Another important agent showing oxi-
dative stress is MDA, a marker of free radical activity [4].
It was reported that oxidative stress significantly elevated
MDA levels and reduced GSH levels [47]. Oxidative
stress has been implicated as an important cause of HSR
pathogenesis [2,46]. The result in present study are con-
sistent with other study who found that a significant
increase in lung MDA level and significant decrease in
lung GSH level were found in hemorrhagic shock group
as compared to sham group in a rat model of hemorrha-
gic shock-induced acute lung injury [18]. In this study
MK-886 significantly reduced the elevation of lung MDA
level and significantly elevates the lung GSH level in the
shocked rats as compared with induced untreated group
suggesting that MK-886 has protective effect in hemor-
rhagic shock-induced oxidative injury of the lung. There
is no data available about the effect of MK-886 on oxida-
tive lung injury in HS. But they found that MK-886 sig-
nificantly reduces hepatic and intestinal MDA level and
elevates GSH level in these organs in rats that underwent
hepatic I/R model and anti-inflammatory properties and
inhibition of lipid peroxidation by MK-886 could be pro-
tective for these organs in I/R injury [18]. The antioxi-
dant effect of MK-886 might be largely due to its
inhibitory action on leukotrienes synthesis.
In the present study a significant increase in the BALF
total protein level was found in the shocked rats as
compared with sham group, suggesting that hemorrha-
gic shock induces lung injury in rats. Increased protein
concentration in BALF is an important marker of
damage to the alveolar-capillary barrier of lung. Further-
more, the increase in BALF total protein concentration
may be due to increased lung permeability and lung
edema during acute lung injury [48]
The acute phase of ALI and ARDS is characterized by
the influx of protein-rich edema fluid into the air spaces
as a consequence of increased permeability of the alveo-
lar-capillary barrier [49]. As previously reported, T/HS
Table 6 Acute lung injury score
Study group Congestion of alveolar septae Intra-alveolar cell infiltrates Alveolar hemorrhage Total score Total score grade
Sham 0 0 0 0 Normal
HS 1.5 ± 0.34 2.5 ± 0.22 1.83 ± 0.16 5.83 ± 0.60* Moderate
MK-886 treated group 0.5 ± 0.22 0.66 ± 0.21 0.17 ± 0.16 1.33 ± 0.42
† Mild
The data expressed as means ± SEM.
* P < 0.05 vs. sham group,
† P < 0.05 vs. HS (induced untreated) group
Figure 10 Photomicrograph of lung section with severe injury.
The section stained with Haematoxylin and Eosin (X 40).
Figure 11 Photomicrograph of lung section with mild injury.
The section stained with Haematoxylin and Eosin (X 40).
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Page 7 of 10caused lung injury as reflected in increased permeability
to Evans blue dye, BALF protein levels and the BALF to
plasma protein ratio [50,51]. Two studies showed that
hemorrhagic shock significantly increases BALF total pro-
tein in the rats and mice [20,29]. CysLTs mediate
increased permeability leading to leukocyte extravasation,
plasma exudation and edema[52, 53, and 54]. Further-
more, LTB4 increases the expression of CD11b/CD18 b2-
integrin (Mac-1) on neutrophils, which can facilitate neu-
trophil adherence and migration [55] and enhanced leuko-
cyte adhesivity accounts for capillary obstruction after I/R
[56]. T/HS lymph induces an increase in endothelial per-
meability by triggering the release of IL-6 [57]. It has been
demonstrated that IL-6 is an important autocrine factor
produced by endothelial cells that contributes to the
increase in endothelial permeability during hypoxia [58].
Free radicals are implicated to damage biomembranes,
thereby compromising cell integrity and function [59].
Besides increasing pulmonary arterial pressure [60], the
free radical production under hypoxic environment may
cause oxidative injury of the endothelium [61], resulting in
increased pulmonary capillary permeability. In this study
treatment with MK-886 appeared to have a significant
decrease in BALF total protein level in the shocked rats in
comparison with the induced untreated group. MK-886
has been shown to reduce the extravasation of plasma [13]
and prevent the leukocyte adhesion to the endothelium
[14] in experimental animals. It was demonstrated that
treatment of mice with MK-886 significantly abolished the
increase in the BALF total protein level in acute lung
injury following hemorrhagic shock [29].
Morphologically, there was a statistically significant dif-
ference between induced untreated group and sham
group and the total score mean of the HS group shows
moderate lung injury. 66.7% of the HS group had moder-
ate lung injury and 33.3% had severe lung injury. Treat-
ment of rats with MK-886 ameliorates the lung injury
significantly as compared with induced untreated group
and the total score mean of the control group shows
mild lung injury. Although there is no data available
about the protective effect of MK-886 on the lung par-
enchyma in HS rats, but they found that MK-886 signifi-
cantly reduces the histological changes in the liver and
small intestine of rats that underwent hepatic I/R model
(15). MK-886 was able to reduce the cortical infarct size
by 30% in a model of focal cerebral ischemia in rats [62].
Furthermore, a separate research work found that treat-
ment of rats with MK-886 reduces brain lesion volume in
experimental traumatic brain injury model [63].
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